Formerly dba Emulate Living MicroDevices, Inc. -- name change in July 2014 -- Emulate, Inc. organizes around commercializing "Organs-on-Chip" -- usefully understood as automated human bioemulation platform representing a new standard for mimicking true human physiology such that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products. In 2017, the firm had been awarded a research grant to use its human Brain-Chip system to develop a research platform to be sent to the International Space Station. Consisting of neuronal and vascular endothelial cells in a micro-engineered environment, the device used to conduct experiments under healthy and inflamed states to assess how space travel affects neuronal function. The firm subsequently announced a new research initiative by which, in collaboration with clinical partners, Emulate will develop unique Organ-Chips personalized with an individualâs living cells. The program has the potential to transform the way the health and treatment of individual person could be managed
